Literature DB >> 12068796

The comprehensiveness care of sickle cell disease.

Iheanyi Okpala1, Veronica Thomas, Neil Westerdale, Tina Jegede, Kavita Raj, Sadie Daley, Hilda Costello-Binger, Jean Mullen, Collis Rochester-Peart, Sarah Helps, Emense Tulloch, Mary Akpala, Moira Dick, Susan Bewley, Mark Davies, Ian Abbs.   

Abstract

Millions of people across the world have sickle cell disease (SCD). Although the true prevalence of SCD in Europe is not certain, London (UK) alone had an estimated 9000 people with the disorder in 1997. People affected by SCD are best managed by a multidisciplinary team of professionals who deliver comprehensive care: a model of healthcare based on interaction of medical and non-medical services with the affected persons. The components of comprehensive care include patient/parent information, genetic counselling, social services, prevention of infections, dietary advice and supplementation, psychotherapy, renal and other specialist medical care, maternal and child health, orthopaedic and general surgery, pain control, physiotherapy, dental and eye care, drug dependency services and specialist sickle cell nursing. The traditional role of haematologists remains to co-ordinate overall management and liase with other specialities as necessary. Co-operation from the affected persons is indispensable to the delivery of comprehensive care. Working in partnership with the hospital or community health service administration and voluntary agencies enhances the success of the multidisciplinary team. Holistic care improves the quality of life of people affected by SCD, and reduces the number as well as length of hospital admissions. Disease-related morbidity is reduced by early detection and treatment of chronic complications. Comprehensive care promotes awareness of SCD among affected persons who are encouraged to take greater control of their own lives, and achieves better patient management than the solo efforts of any single group of professionals. This cost-effective model of care is an option for taking haemoglobinopathy services forward in the new millennium.

Entities:  

Mesh:

Year:  2002        PMID: 12068796     DOI: 10.1034/j.1600-0609.2002.01523.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  13 in total

1.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

2.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

3.  Penicillin prophylaxis in children with sickle cell disease.

Authors:  Mary Petrea Cober; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2010-07

4.  Utilization of the office, hospital and emergency department for adult sickle cell patients: a five-year study.

Authors:  Kenneth Epstein; Elaine Yuen; Jeff M Riggio; Samir K Ballas; Stephanie M Moleski
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

5.  Abnormal haemoglobin variants, ABO and Rh blood groups among student of African descent in Port Harcourt, Nigeria.

Authors:  Zaccheaus Awortu Jeremiah
Journal:  Afr Health Sci       Date:  2006-09       Impact factor: 0.927

6.  Health-related quality of life in children with sickle cell disease using the child health questionnaire.

Authors:  Brian H Wrotniak; Joan I Schall; Megan E Brault; Dorene F Balmer; Virginia A Stallings
Journal:  J Pediatr Health Care       Date:  2012-11-08       Impact factor: 1.812

7.  Sickle cell disease in California: sociodemographic predictors of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Rachna Khanna; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

8.  Association of care in a medical home and health care utilization among children with sickle cell disease.

Authors:  Jean L Raphael; Tiffany L Rattler; Marc A Kowalkowski; David C Brousseau; Brigitta U Mueller; Thomas P Giordano
Journal:  J Natl Med Assoc       Date:  2013       Impact factor: 1.798

9.  Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study.

Authors:  Imoigele P Aisiku; Lynne T Penberthy; Wally R Smith; Viktor E Bovbjerg; Donna K McClish; James L Levenson; John D Roberts; Susan D Roseff
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

10.  Twelve tips for teaching a comprehensive disease-focused course with a global perspective: A sickle cell disease example.

Authors:  Dominique Bulgin; Paula Tanabe; Monika Asnani; Charmaine D M Royal
Journal:  Med Teach       Date:  2018-01-15       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.